Viewing Study NCT00791232

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2026-06-30 @ 12:39 PM
Study NCT ID: NCT00791232
Status: COMPLETED
Last Update Posted: 2011-06-08
First Post: 2008-11-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schizophrenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Extended-release paliperidone View
None Schizophrenia, Mood disorders, Antipsychotic drugs View
None ER OROS paliperidone View